Reply #42: Actually, Guy, they did appoint a woman, Theresa Toigo [View All]

[Catshrink]

They got smart:

This is a release from the FDA's website today http://www.fda.gov/bbs/topics/news/2005/toigoOWH.html

Theresa A. Toigo Is Appointed Acting Director of FDA's Office of Women's Health

U.S. Food and Drug Administration Commissioner Lester M. Crawford today announced the appointment of Theresa A. Toigo as the Acting Director of FDA's Office of Women’s Health. Ms. Toigo also serves as the Director of FDA’s Office of Special Health Issues (OSHI).

"Terry brings more than 20 years of exemplary public service mostly as a patient advocate at FDA to this important position," said Dr. Crawford.

The U.S. Food and Drug Administration's Office of Women's Health (OWH) serves as a champion for women's health both within and outside the agency. To achieve its goals, OWH:

<snip>

As Director of FDA's Office of Special Health Issues, Ms. Toigo led the office that serves as the agency’s primary liaison with patients and their advocates to encourage and support their active participation in the formulation of FDA regulatory policy. OSHI serves as a channel through which patient issues and viewpoints can be brought to the attention of FDA medical and regulatory staff. OSHI also works with cancer and HIV patients and advocacy programs on issues related to the FDA drug approval process, clinical trials and access to investigational therapies.

Ms. Toigo has held various FDA positions in CDER, CBER and the Office of the Commissioner since joining FDA in 1984. Ms. Toigo has collaborated with the Office of Women’s Health on a variety of FDA initiatives related to the inclusion of women and minorities in clinical trials. Ms. Toigo received her pharmacy (BS) and business (MBA) degrees from Rutgers University.